These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 15710567

  • 1. Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo.
    Levac K, Karanu F, Bhatia M.
    Haematologica; 2005 Feb; 90(2):166-72. PubMed ID: 15710567
    [Abstract] [Full Text] [Related]

  • 2. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G, Milazzo L, Vulcano F, Pascuccio M, Macioce G, Hassan HJ, Giampaolo A.
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [Abstract] [Full Text] [Related]

  • 3. Different growth factor requirements for the ex vivo amplification of transplantable human cord blood cells in a NOD/SCID mouse model.
    Bruno S, Gammaitoni L, Gunetti M, Sanavio F, Fagioli F, Aglietta M, Piacibello W.
    J Biol Regul Homeost Agents; 2001 Feb; 15(1):38-48. PubMed ID: 11388743
    [Abstract] [Full Text] [Related]

  • 4. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T, Schröder B, Bug G, Müller P, Klenner T, Knaus R, Hoelzer D, Ottmann OG.
    Stem Cells; 2001 Feb; 19(4):313-20. PubMed ID: 11463951
    [Abstract] [Full Text] [Related]

  • 5. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D, Goan SR, Junghahn I, Winkler J, Fichtner I, Hermann M, Becker M, de Lima-Hahn E, Henschler R.
    Stem Cells; 1999 Feb; 17(3):152-61. PubMed ID: 10342558
    [Abstract] [Full Text] [Related]

  • 6. The plant mannose-binding lectin NTL preserves cord blood haematopoietic stem/progenitor cells in long-term culture and enhances their ex vivo expansion.
    Li K, Ooi VE, Chuen CK, Lam AC, Ooi LS, Zhang XB, Tsang KS, Chiu LC, Chan KY, Li CK, Fok TF, Yuen PM, Ng PC.
    Br J Haematol; 2008 Jan; 140(1):90-8. PubMed ID: 17908183
    [Abstract] [Full Text] [Related]

  • 7. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
    Fei XM, Wu YJ, Chang Z, Miao KR, Tang YH, Zhou XY, Wang LX, Pan QQ, Wang CY.
    Cytotherapy; 2007 Jan; 9(4):338-47. PubMed ID: 17573609
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo megakaryocyte differentiation of fresh and ex-vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution.
    Bruno S, Gunetti M, Gammaitoni L, Danè A, Cavalloni G, Sanavio F, Fagioli F, Aglietta M, Piacibello W.
    Haematologica; 2003 Apr; 88(4):379-87. PubMed ID: 12681964
    [Abstract] [Full Text] [Related]

  • 9. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor.
    Ueda T, Tsuji K, Yoshino H, Ebihara Y, Yagasaki H, Hisakawa H, Mitsui T, Manabe A, Tanaka R, Kobayashi K, Ito M, Yasukawa K, Nakahata T.
    J Clin Invest; 2000 Apr; 105(7):1013-21. PubMed ID: 10749580
    [Abstract] [Full Text] [Related]

  • 10. Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34+ stem/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis.
    Yang M, Li K, Ng PC, Chuen CK, Lau TK, Cheng YS, Liu YS, Li CK, Yuen PM, James AE, Lee SM, Fok TF.
    Stem Cells; 2007 Jul; 25(7):1800-6. PubMed ID: 17446559
    [Abstract] [Full Text] [Related]

  • 11. Small peptide analogue of SDF-1alpha supports survival of cord blood CD34+ cells in synergy with other cytokines and enhances their ex vivo expansion and engraftment into nonobese diabetic/severe combined immunodeficient mice.
    Li K, Chuen CK, Lee SM, Law P, Fok TF, Ng PC, Li CK, Wong D, Merzouk A, Salari H, Gu GJ, Yuen PM.
    Stem Cells; 2006 Jan; 24(1):55-64. PubMed ID: 16123381
    [Abstract] [Full Text] [Related]

  • 12. Ex vivo expansion of stem cells: defining optimum conditions using various cytokines.
    Mohamed AA, Ibrahim AM, El-Masry MW, Mansour IM, Khroshied MA, Gouda HM, Riad RM.
    Lab Hematol; 2006 Jan; 12(2):86-93. PubMed ID: 16751136
    [Abstract] [Full Text] [Related]

  • 13. Role of different medium and growth factors on placental blood stem cell expansion: an in vitro and in vivo study.
    Berger M, Fagioli F, Piacibello W, Sanavio F, Mareschi K, Biasin E, Bruno S, Gammaitoni L, Gunetti M, Nesi F, Madon E, Aglietta M.
    Bone Marrow Transplant; 2002 Mar; 29(5):443-8. PubMed ID: 11919735
    [Abstract] [Full Text] [Related]

  • 14. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
    Feng JF, Zhuang M, Zhu LJ, Sheng ZL, Zhu YQ, Li CP.
    Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
    Lazzari L, Henschler R, Lecchi L, Rebulla P, Mertelsmann R, Sirchia G.
    Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
    [Abstract] [Full Text] [Related]

  • 16. Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy.
    Li K, Li CK, Chuen CK, Tsang KS, Fok TF, James AE, Lee SM, Shing MM, Chik KW, Yuen PM.
    Eur J Haematol; 2005 Feb; 74(2):128-35. PubMed ID: 15654904
    [Abstract] [Full Text] [Related]

  • 17. The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors.
    Kögler G, Callejas J, Sorg RV, Fischer J, Migliaccio AR, Wernet P.
    Bone Marrow Transplant; 1998 Feb; 21(3):233-41. PubMed ID: 9489645
    [Abstract] [Full Text] [Related]

  • 18. Ex vivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model.
    van Hensbergen Y, Schipper LF, Brand A, Slot MC, Welling M, Nauta AJ, Fibbe WE.
    Exp Hematol; 2006 Jul; 34(7):943-50. PubMed ID: 16797422
    [Abstract] [Full Text] [Related]

  • 19. Platelet-derived growth factor enhances ex vivo expansion of megakaryocytic progenitors from human cord blood.
    Su RJ, Li K, Yang M, Zhang XB, Tsang KS, Fok TF, Li CK, Yuen PM.
    Bone Marrow Transplant; 2001 May; 27(10):1075-80. PubMed ID: 11438824
    [Abstract] [Full Text] [Related]

  • 20. Synergistic effects of hepatocyte growth factor on human cord blood CD34+ progenitor cells are the result of c-met receptor expression.
    Goff JP, Shields DS, Petersen BE, Zajac VF, Michalopoulos GK, Greenberger JS.
    Stem Cells; 1996 Sep; 14(5):592-602. PubMed ID: 8888500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.